Commissioner - District 1 at Newton County
Employing Organization
Team
Decision makers at Newton County
911 Director
Auditor
Building Commissioner
Captain
Key decision makers in the same organization
Organization Signals
Board meetings, strategic plans, and buyer signals from Steven Eilers’s organization
The Board discussed various drainage projects including the Lake Village Ditch correction, fall projects for Edward Madison Lateral Tile, Kindig Combination, and Beaver Creek, as well as property history for Maple Brook Terrace. Additionally, the Board addressed invoices for the Sumava drainage maintenance fund and scheduled maintenance for the joint Hunter Ditch.
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Verified emails & phones
Accuracy-guaranteed data
Job-change & title updates
Never lose a contact
The board meeting focused on several key agenda items, including a review of the Priority Drug List (PDL) report and the need for legislative changes regarding outdated reporting requirements. The board reviewed call center statistics for Preliminary Authorization (PA) and point-of-sale verification. Additionally, there was a discussion on opioid usage trends, stable MME distribution, and exemptions for high-dose users. The board also addressed concurrent therapy guidelines for stimulants and benzodiazepines, noting the risks of substance use disorders and proposing retrospective analyses of insurance claims to identify and support participants in high-risk concurrent therapy.
The public hearing was held to discuss proposed rule amendments at 440 IAC 10 concerning opioid treatment programs. The proceedings included instructions for submitting oral and written comments, a review of the small business economic impact statement, and the identification of LSA document number 25-797 for public correspondence.
The DUR Board meeting covered various clinical recommendations and updates. Key discussions included PA and opioid utilization statistics for May and June 2026. The board reviewed and approved recommendations for respiratory agents, anti-infective medications, cardiovascular treatments, lipotropics, and anti-migraine therapies, including adjustments to status, quantity limits, and step therapy requirements for several drug classes.
Extracted from official board minutes, strategic plans, and video transcripts.
Organization signals
Board meetings and buying signals
Salesforce & HubSpot sync
Native two-way integration
